T-cell engagers (TCEs) are a growing class of biotherapeutics being investigated in the clinic for treatment of a variety of hematological and solid tumor indications. However, preclinical evaluation ...
Immunomodulatory approaches for cancer therapy have demonstrated promising clinical efficacy in recent years, leading to multiple approved therapeutics. Such therapeutics have focused on enhancing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results